Inhibiting BCAA metabolism (such as using BCAT1 inhibitors) can reverse resistance and enhance cancer cells’ sensitivity to chemotherapy, targeted therapy, and immunotherapy (Table 2). The gene discussed is BCAT1; the disease is cancer.